Despite their transformative potential, liquid biopsies face significant barriers to widespread adoption, including sensitivity limitations, high costs, and inconsistent reimbursement policies. While the market has grown exponentially, these challenges threaten to slow progress, particularly in regions with limited healthcare resources. Addressing these issues is critical to ensuring liquid...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt